Efficacy and safety of sitafloxacin (STFX) in tonsillar abcess; prospective study in outpatient setting.
Phase of Trial: Phase II
Latest Information Update: 02 Apr 2019
Price : $35 *
At a glance
- Drugs Sitafloxacin (Primary)
- Indications Bacterial infections; Peritonsillar abscess
- Focus Therapeutic Use
- 29 Mar 2019 Status changed from recruiting to discontinued.
- 06 Jun 2014 New trial record